Elanco Animal Health (ELAN) Depreciation & Amortization (CF) (2017 - 2026)

Elanco Animal Health has disclosed Depreciation & Amortization (CF) across 10 years of filings, most recently posting $172.0 million for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $172.0 million, up 6.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $691.0 million (up 5.18% YoY), and the FY2025 annual result was $680.0 million, up 2.72% from the prior year.
• Depreciation & Amortization (CF) came in at $172.0 million for Q1 2026 at Elanco Animal Health, down from $174.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $177.0 million in Q2 2023 to a low of $161.0 million in Q1 2025.
• The 5-year median for Depreciation & Amortization (CF) is $171.0 million (2022), against an average of $170.0 million.
• Across the five-year window, Depreciation & Amortization (CF) declined 12.87% in 2022 and grew 6.83% in 2026, its largest moves.
• Elanco Animal Health's Depreciation & Amortization (CF) stood at $168.0 million in 2022, then advanced by 1.79% to $171.0 million in 2023, then fell by 4.09% to $164.0 million in 2024, then climbed by 6.1% to $174.0 million in 2025, then retreated by 1.15% to $172.0 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $172.0 million (Q1 2026), $174.0 million (Q4 2025), and $176.0 million (Q3 2025), per Business Quant data.